Paper166332
Studies on the antiparkinsonism efficacy of lergotrile.
Lieberman A and 3 others. Neurology, 1975. Cited by 81 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Studies on the antiparkinsonism efficacy of lergotrile. Papers, record 166332. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/166332
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Acetonitriles | Major topic |
| Ergolines | Major topic |
| Parkinson Disease | Major topic |
| Prolactin | Major topic |
| Aged | |
| Animals | |
| Disease Models, Animal | |
| Dopamine | |
| Dose-Response Relationship, Drug | |
| Drug Evaluation | |
| Drug Evaluation, Preclinical | |
| Female | |
| Gait | |
| Haplorhini | |
| Humans | |
| Male | |
| Mesylates | |
| Middle Aged | |
| Muscle Rigidity | |
| Receptors, Drug | |
| Tremor |
Source PubMed
Cited by17
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 81 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 22,216,518 | Bromocriptine and dopamine receptor stimulation. | Br J Clin Pharmacol | 1976 | https://conductscience.org/library/papers/22216518 | PubMed |
| 17,967,735 | Behavioural supersensitivity following neonatal 6-hydroxydopamine: attenuation by MK-801. | Neurotox Res | 2007 | https://conductscience.org/library/papers/17967735 | PubMed |
| 12,832,225 | Effects of acute administration of DA agonists on locomotor activity: MPTP versus neonatal intracerebroventricular 6-OHDA treatment. | Neurotox Res | 2003 | https://conductscience.org/library/papers/12832225 | PubMed |
| 6,932,044 | Interaction of pergolide with central dopaminergic receptors. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6932044 | PubMed |
| 6,435,991 | Anti-parkinsonian drugs today. | Drugs | 1984 | https://conductscience.org/library/papers/6435991 | PubMed |
| 6,101,955 | Cross tolerance between two dopaminergic ergot derivatives--bromocriptine and lergotrile. | Br J Clin Pharmacol | 1980 | https://conductscience.org/library/papers/6101955 | PubMed |
| 1,268,610 | Editorial: Alternatives to levodopa. | Br Med J | 1976 | https://conductscience.org/library/papers/1268610 | PubMed |
| 782,834 | Levodopa and decarboxylase inhibitors: a review of their clinical pharmacology and use in the treatment of parkinsonism. | Drugs | 1976 | https://conductscience.org/library/papers/782834 | PubMed |
| 772,175 | Bromocriptine treatment in Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1976 | https://conductscience.org/library/papers/772175 | PubMed |
| 720,482 | Antiparkinsonian drug doses and neuroleptic receptors. | Experientia | 1978 | https://conductscience.org/library/papers/720482 | PubMed |
| 641,542 | Effect of lergotrile on 3,4-dihydroxyphenylacetic acid (DOPAC) concentration and dopamine turnover in rat brain. | J Neural Transm | 1978 | https://conductscience.org/library/papers/641542 | PubMed |
| 591,982 | Bromocriptine alone or associated with L-dopa plus benserazide in Parkinson's disease. | J Neurol Neurosurg Psychiatry | 1977 | https://conductscience.org/library/papers/591982 | PubMed |
| 490,153 | EEG sleep patterns in Parkinsonian patients treated with bromocryptine and L-dopa: a comparative study. | J Neural Transm | 1979 | https://conductscience.org/library/papers/490153 | PubMed |
| 407,600 | The production of an alternative laboratory model of the Parkinson syndrome using a new benzylimidoylurea derivative LON 954. | Psychopharmacology (Berl) | 1977 | https://conductscience.org/library/papers/407600 | PubMed |
| 44,446 | N-demethylation of lergotrile by Streptomyces platensis. | Appl Environ Microbiol | 1979 | https://conductscience.org/library/papers/44446 | PubMed |
| 37,066 | Bromocriptine in the treatment of parkinsonism. | Drugs | 1979 | https://conductscience.org/library/papers/37066 | PubMed |
| 21,229 | The interactions of bromocriptine and lergotrile with dopamine and alpha-adrenergic receptors. | J Neural Transm | 1977 | https://conductscience.org/library/papers/21229 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/166332
GET https://conductscience.org/api/papers/v1/166332/authors